Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1 Hossein Ardehali Hossein Ardehali View: Text | PDF Viewpoint Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1 Text PDF Abstract Authors Hossein Ardehali Figure 1 Mechanism of GLP-1 production and its beneficial effects
Degarelix Various trials comparing Degarelix to LH-RH agonists, identified differences 49 with the rate of progression, of PSA, cardiovascular (CV) event rate, and overall survival, significantly favoring Degarelix
In vitro biodegradation As shown in Fig
### US vs International Pricing | Country | Compounded Monthly Cost | Notes | |---------|------------------------|-------| | United States | $250-650 | Largest market, most options | | United Kingdom | 200-500 | Growing availability | | Canada | CAD $300-550 | Limited compounding access | | Australia | AUD $350-600 | Emerging market | | India | $50-150 | Lower cost, verify quality | ## Red Flags When Purchasing Avoid any source that: - Does not require a valid prescription - Ships from outside the United States - Prices more than 50% below market average - Cannot provide a Certificate of Analysis (COA) - Accepts only cryptocurrency or wire transfer - Has no verifiable pharmacy license ### Safe Purchasing Checklist - US-licensed 503A or 503B compounding pharmacy - Valid prescription from a licensed prescriber required - Certificate of Analysis available for each batch - Proper cold-chain shipping (insulated packaging with ice packs) - Clear return/refund policy - Responsive customer service *Medical disclaimer: Retatrutide is investigational and not FDA approved
